Produced by: Bullet Caiguan
November 19th news, a listed company in the oral and assisted reproductive medical industry, Tongce Medical issued an announcement on November 18, disclosing that the company's actual controller and chairman Lu Jianming has been investigated by the China Securities Regulatory Commission for suspected illegal and irregular information disclosure.
Lu Jianming was investigated mainly because it involved the information disclosure of Zhejiang Tongce No. 1 Investment Partnership (Limited Partnership). On October 11 this year, Tongce Medical issued an "Announcement on the Rectification Report on the Decision on Administrative Supervision Measures of the Zhejiang Securities Regulatory Bureau", which disclosed Lu Jianming's specific problems:
From October 19 to December 30, 2021, the company had non-operating financial transactions with the enterprises controlled by the actual controller, involving an amount of RMB 143.2 million, but the company failed to fulfill the corresponding decision-making procedures in accordance with regulations and failed to fulfill the information disclosure obligations.
Lu Jianming also had inaccurate disclosure of financial assistance and investment investment. The announcement mentioned: "The related parties controlled by the actual controller were in 2018-2020 During the year period, no financial assistance was provided in the same proportion, and other shareholders did not provide financial assistance as of the day of inspection. The actual situation of financial assistance is inconsistent with the disclosure of the announcement. "
In addition, Tongce Medical also has the problem of lack of independence of listed companies:
" In terms of seal management, the company has the situation of using the same OA system for approval with the relevant party seal management controlled by the actual controller. In terms of personnel management, there is a situation where the company's financial personnel apply to use the listed company seal and the related party seal at the same time. In terms of fund management, there is a situation where the related party fund payment is approved by the financial personnel of the listed company. "
Tongce Medical stated that all of these problems have been rectified.
Public information shows that Tongce Medical was established in 1995. They are the first listed company in A-share with oral medical chain operation as the main model. The company was once called "Taita" because of the rise in 's share price .
According to Tongce Medical's recent financial report for the third quarter of 2022, they achieved revenue of 821.2 million yuan in the third quarter, increased by only 0.29% year-on-year, and net profit was 219.6 million yuan, a year-on-year decrease of 18.47%, and net profit excluding non-network was 210.7 million yuan, a year-on-year decrease of 20.74%.
In the first three quarters of this year, Tongce Medical's total revenue was 2.139 billion yuan, a year-on-year increase of 0.14%, and net profit was 515.2 million yuan. fell 16.92% year-on-year compared with .
Lu Jianming graduated from the Chinese Department of Hangzhou University in 1988. After graduation, he worked for the Zhejiang Provincial Disabled Persons Federation. In 1992, Lu Jianming resigned and went into a real estate company for sales. In 1995, he established Zhejiang Tongce Real Estate Development Co., Ltd. In 2003, Lu Jianming established Zhejiang Tongce Holding Group Co., Ltd. , , and in the second year, he acquired Hangzhou Dental Hospital to enter the oral medical industry. Tongce Medical completed its share reform in 2006 and went public through a backdoor listing in 2007.
On October 24 this year, Lu Jianming also participated in the research activity of Tongce Medical Co., Ltd. and answered questions from the research institutions. When asked about expectations for 2023, Tongce Medical Management, including Lu Jianming, said: The company is confident and optimistic about growth next year and is expected to return to normal growth levels.
